Simulations Plus, Inc. Logo

Simulations Plus, Inc.

Modeling & simulation software and consulting for pharma/biotech to accelerate drug development.

SLP | NDAQ

Overview

Corporate Details

ISIN(s):
US8292141053
LEI:
Country:
United States of America
Address:
800 PARK OFFICES DRIVE, SUITE 401, 27709 RESEARCH TRIANGLE PARK
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Simulations Plus, Inc. is a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and other science-based industries. The company specializes in solutions that support drug discovery and development, from early research and clinical development to regulatory submissions. Its flagship products, including GastroPlus® and ADMET Predictor®, utilize advanced technologies like AI/machine learning, physiologically based pharmacokinetic (PBPK), quantitative systems pharmacology (QSP), and quantitative systems toxicology (QST) modeling. These tools enable scientists to predict the properties and effects of chemical and biological compounds, helping to optimize drug design, predict safety and efficacy, and accelerate the development timeline. The company serves a global client base, including major pharmaceutical companies, regulatory agencies, and academic institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Simulations Plus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Simulations Plus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Simulations Plus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
LAMAR ADVERTISING CO/NEW Logo
A leading OOH advertising REIT with billboards, transit, and airport displays in the US & Canada.
United States of America LAMR
Larimar Therapeutics, Inc. Logo
Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.
United States of America LRMR
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.
United States of America LPTX
Lidds AB Logo
Develops oncology drugs using a technology for local, controlled, and sustained drug release.
Sweden LIDDS
LigaChem Biosciences Inc. Logo
Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.
South Korea 141080
LIGAND PHARMACEUTICALS INC Logo
Acquires drug royalties and licenses proprietary technologies to biopharmaceutical partners.
United States of America LGND
LIKE,Inc. Logo
Provides comprehensive lifestyle support in childcare, human resources, and nursing care services.
Japan 2462
Linical Co., Ltd. Logo
Global CRO providing full-service drug development support for biopharma companies.
Japan 2183
Linkers Corporation Logo
A technology matchmaking platform for manufacturers to solve challenges and foster innovation.
Japan 5131
Lipidor AB Logo
Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.
Sweden LIPI

Talk to a Data Expert

Have a question? We'll get back to you promptly.